Neprilysin inhibition to treat heart failure: a tale of science, serendipity, and second chances.

European Journal of Heart Failure
John McMurray

Abstract

This review describes the role of neprilysin (also known as neutral endopeptidase or enkephalinase) in the degradation of natriuretic and other vasoactive peptides, including bradykinin and adrenomedullin. The initial development of neprilysin inhibitors, then angiotensin converting enzyme-neprilysin inhibitors and, most recently, the angiotensin receptor neprilysin inhibitor (ARNI) LCZ696 (sacubitril valsartan) as an extension of the nurohumoral basis for the treatment of heart failure is also summarised. Finally, the implications of the compelling benefits of LCZ696 compared with enalapril in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF) is discussed.

References

Aug 1, 1991·The New England Journal of Medicine·UNKNOWN SOLVD InvestigatorsJay N Cohn
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·C GrosJ M Lecomte
Sep 9, 1989·Lancet·D B NorthridgeG M Samuels
Jan 1, 1987·Cardiovascular Drugs and Therapy·B S EdwardsJ C Burnett
Nov 1, 1968·The Biochemical Journal·Y L Wong-Leung, A J Kenny
Sep 1, 1981·American Heart Journal·J N CohnS Goldsmith
Sep 1, 1984·Annals of Internal Medicine·G S FrancisJ N Cohn
May 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·R MatsasA J Turner
Dec 28, 1983·Biochemical and Biophysical Research Communications·T G FlynnA J de Bold
Jan 13, 1984·Biochemical and Biophysical Research Communications·K Kangawa, H Matsuo
Sep 1, 1994·British Journal of Pharmacology·Z A AbassiH R Keiser
Apr 24, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Nicholas L M CrudenDavid E Newby
Dec 13, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Yong-Mei ChaAndre Terzic
Dec 7, 2007·The American Journal of Medicine·Hani JneidGary S Francis
Jun 3, 2008·American Heart Journal·Hartmut LüssMarkus Meyer
Jul 8, 2011·The New England Journal of Medicine·C M O'ConnorR M Califf
Aug 31, 2012·Lancet·Scott D SolomonUNKNOWN Prospective comparison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion (PARAMOUNT) Investig
Nov 6, 2012·Journal of the American College of Cardiology·Horng H ChenJohn C Burnett

❮ Previous
Next ❯

Citations

Mar 1, 2016·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·Á KovácsN Hamdani
Mar 1, 2016·Expert Review of Cardiovascular Therapy·Roberto LatiniLidia Staszewsky
Mar 11, 2015·European Journal of Heart Failure·Marco Metra
May 21, 2016·European Journal of Heart Failure·Massimo VolpeVittoria Mastromarino
Jun 11, 2016·Drug and Therapeutics Bulletin
Dec 3, 2015·Journal of Clinical Pharmacology·Elaine NguyenC Michael White
Jul 28, 2016·Pharmacology & Therapeutics·Achim Lother, Lutz Hein
Sep 22, 2016·Journal of Diabetes Research·Stella BernardiBruno Fabris
Sep 30, 2016·Journal of Cardiovascular Medicine·Dimitrios FarmakisGerasimos Filippatos
Oct 6, 2016·European Journal of Heart Failure·Marco Metra
Nov 14, 2016·International Journal of Cardiology·Marco MetraAndrew J Stewart Coats
Oct 16, 2016·Heart·Athar Ali Tajik, Kenneth Dickstein
Dec 3, 2016·European Journal of Heart Failure·Stephan von HaehlingStefan D Anker
Feb 7, 2017·Drug Delivery·Tausif AlamJaved Ali
Jun 16, 2016·Scientific Reports·Nikolaus SchieringMuneto Mogi
Mar 23, 2017·European Journal of Heart Failure·Emilia D'EliaMichele Senni
Apr 20, 2017·Journal of Medicinal Chemistry·Andrew C FlickChristopher J O'Donnell
Jun 3, 2017·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Carlos M Ferrario, Adam E Mullick
Jun 7, 2017·European Journal of Heart Failure·Marco Metra
Oct 31, 2017·Journal of Cardiovascular Medicine·Marco Metra
Nov 14, 2017·ESC Heart Failure·Amir EmamiStephan von Haehling
Jul 10, 2017·Heart·Jagdeep S S SinghChim C Lang
Jun 20, 2018·Journal of Cardiovascular Medicine·Edoardo SciattiMarco Metra
Dec 9, 2017·Circulation Research·Susan Ince
Oct 28, 2018·Nature Reviews. Cardiology·Magdi H Yacoub, Christopher McLeod
Jun 1, 2018·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Rex C Liu
Sep 20, 2019·The New England Journal of Medicine·John J V McMurrayUNKNOWN DAPA-HF Trial Committees and Investigators
Aug 27, 2019·Current Topics in Medicinal Chemistry·Shihui FuJuelin Deng
Jan 4, 2020·European Heart Journal·John J V McMurrayPardeep S Jhund
Aug 3, 2019·Journal of the Saudi Heart Association·Waleed AlHabeebWalid Hassan
May 5, 2020·European Journal of Heart Failure·Pooja DewanJohn J V McMurray
Nov 22, 2016·European Journal of Heart Failure·Jane A CannonUNKNOWN PARADIGM-HF Investigators and Committees
Dec 19, 2019·Cardiovascular Research·Alain Cohen-Solal, Damien Logeart
Feb 6, 2017·Journal of Peptide Science : an Official Publication of the European Peptide Society·Ria SchönauerAnnette G Beck-Sickinger
May 16, 2018·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Inder Anand
May 16, 2019·Nature Chemical Biology·Juan Pablo MaiantiDavid R Liu
Nov 11, 2021·The New England Journal of Medicine·Marc A PfefferUNKNOWN PARADISE-MI Investigators and Committees

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.